PREVLAR: Phase 2a randomized trial to assess the safety and efficacy of RRx-001 in the attenuation of oral mucositis in patients receiving head and neck chemoradiotherapy.
暂无分享，去创建一个
K. Niermann | D. Sher | M. Biagioli | V. Takiar | V. Bar-ad | S. Sonis | T. Reid | S. Goyal | D. Blakaj | B. Oronsky | R. Kabarriti | S. Caroen | K. Colvett | Nacer D. Abrouk | RuMarcelo Bonomi | Brian Muzyka | B. Muzyka